Sign up Australia
Proactive Investors - Run By Investors For Investors

Small-Cap Snapshot: CTI BioPharma shares sink after late-stage trial of its cancer drug disappoints

The Phase 3 trial of its treatment for non-Hodgkin's lymphoma didn't meet the goals of the study
Small-Cap Snapshot: CTI BioPharma shares sink after late-stage trial of its cancer drug disappoints
Shares of the oncology biotech dropped by double digits

CTI BioPharma Corp (NASDAQ:CTIC) shares fell after a disappointing late-stage trial of its cancer drug. The Phase 3 trial of its treatment for non-Hodgkin's lymphoma failed to meet its main goals. The trial included more than 300 patients who had relapsed and were not eligible for stem cell transplant. Shares of the Washington-based biotech fell more than 14% to US$4.47.

Helen of Troy Ltd (NASDAQ:HELE) shares were up following a strong fiscal first quarter. The personal and household products company reported earnings of US$1.87 per share on revenue of US$354.68mln compared with analyst estimates of US$1.46 EPS on revenue of US$333.75mln. Its brand portfolio includes Revlon, Vicks, Dr. Scholl’s and Honeywell. Shares of the Bermuda-based company rose more than 13% to US$115.34 in Monday morning trading.

READ: Helen of Troy stock soars after fiscal 1Q earnings beat Street

Groupon Inc (NASDAQ:GRPN) shares jump after weekend reports that the coupon company was looking for a buyer. The company has allegedly been contacting public companies to see if there was any interest, according to a Recode report. The company has been independently run for the last 10 years. Shares of the Chicago-based company were up nearly 5% to US$4.57.

MabVax Therapeutics Holdings Inc (NASDAQ:MBVX) saw its shares nearly quadruple after news that Boehringer Ingelheim has acquired the rights to its antibody development program in a US$11mln deal. The program targets a chemical compound commonly seen on multiple solid tumor cancers. The clinical-stage biotech focuses on the development of cancer treatments. Shares of the California-based company jumped more than 280% to US$2.25.

 

Contact Lenore Fedow at [email protected]

Follow her on Twitter@LenoreMariee

 

View full CTIC profile View Profile

CTI BioPharma Corp Timeline

Related Articles

Oncoprex
October 18 2018
The biotech was founded by an investment group led by scientists and driven by a no-nonsense CEO whose stake is more than just business as usual
woman at a microscope
August 02 2018
Currently undergoing phase III clinical trials, AP101 is being developed to treat Epidermolysis Bullosa, a condition which occurs prominently in children and makes skin fragile to even the faintest touch
Cancer cells
June 27 2018
The Nottingham-based privately-owned company has made an impressive fist of developing the OMIS (Opto-magnetic Imaging Spectroscopy) cancer detection system

© Proactive Investors 2018

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use